Nexentis Technologies NXTS
NASDAQ NXTS
$2.51 +2.00 (+392.16%)
At close: Nov 9, 2026 · 4:00 PM EST

Nexentis Technologies (NXTS) Depreciation & Amortization - Total (2026)

Updated

Nexentis Technologies (NXTS) posted Depreciation & Amortization - Total of $4,000 for Q2 2026.

Analysis

Nexentis Technologies (NXTS) Depreciation & Amortization - Total (2026) Analysis & Trends

For FY2025, Nexentis Technologies' Depreciation & Amortization - Total came in at $1,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Nexentis Technologies 2.04 Mn -23.39 Mn - 4,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4,000.00
API Access

Nexentis Technologies Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=NXTS&period=max&api_key=YOUR_API_KEY